This page shows the latest hematology news and features for those working in and with pharma, biotech and healthcare.
A round-up of some of the key data from the annual American Society of Hematology (ASH) meeting. ... It was a bumper year at the annual American Society of Hematology (ASH) meeting, with a slew of new data presented across the board.
CML). The detailed results, presented at the annual American Society of Hematology (ASH) meeting, come from the phase 3 ASCEMBL study.
Results from a phase 1 clinical trial of the ADC, which are due to be presented at the upcoming virtual American Society of Hematology Annual Meeting, demonstrated that VLS-101 treatment
The approval comes just days ahead of a number of important phase 3 read outs for Zynteglo at the European Hematology Association (EHA) congress in Amsterdam.
with advances being made in new disease types,” said Richard Pazdur, director of the FDA’s Oncology Center of Excellence and acting director of the Office of Hematology and Oncology Products
first investigator to administer daratumumab in human trials and Professor, head of the department of hematology at Vejle Hospital, Denmark.
More from news
Approximately 6 fully matching, plus 52 partially matching documents found.
A brief glance at the programme for the major US haematology congress, held by the American Society of Hematology, tells its own story, with most sessions being dedicated to haematological malignancies
This does not typically include royalty payments. 2. Ataga et al, Abstract, American Society of Hematology (ASH), December 2016.
Portfolio of early-stage hematology candidates &option for recombinant pegasparaginase. Licence, option.
More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.
Most recently, Dr Obrocea was AbbVie Biotherapeutics' project director and oncology clinical lead, overseeing a number of trials in oncology and hematology.
Prof Chiara Bonini (pictured left) is currently head of the experimental hematology unit at the San Raffaele Scientific Institute, a position she has held since 2008.
More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.
Learn how one of our clients used the Impetus InSite Platform to connect their MSLs with regional groups of physicians. In this customer story, we summarize the outcomes from an ongoing project where our client is leveraging a variety of Impetus
Earlier this month, Porterhouse Medical attended the 60. th. American Society of Hematology (ASH) Annual Meeting (). The ASH congress is the most comprehensive haematology event of the year, attracting 25, 000
Now in its 60th year the American Society of Hematology (ASH) annual meeting and exposition is the premier event in malignant and non-malignant hematology. ... The meeting provides an invaluable educational experience and the opportunity to review
Society of Hematology XXXVI World Congress in Congress ( ISH), which was hosted by the British Society for Haematology at the 56th Annual Scientific Meeting, between 18th-21st April.
number of key therapeutic areas such endocrinology, neurology, oncology, hematology, women’s health and rare diseases.
More from PMHub
Approximately 3 fully matching, plus 7 partially matching documents found.
HME are an innovative and technology enabled agency offering our clients over 35+ years of knowledge and expertise in delivering...